series-c-plus
Stage
1
Investors
About
Cerus Corporation develops and supplies pathogen-reduction technologies and pathogen-protected blood components to enhance blood safety for blood centers, hospitals, and patients globally.
Explore Cerus Corporation's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.